NDAOralTablet
Approved
Apr 2001
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
4/8 — Partial
AVELOX (moxifloxacin hydrochloride) by R-Pharm US is [see clinical pharmacology ()]. Approved for community-acquired pneumonia, copd exacerbation, bacterial conjunctivitis and 1 more indications. First approved in 2001.
Drug data last refreshed 22h ago
Mechanism of Action
[see Clinical Pharmacology ()].
Worked on AVELOX at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.